![Jeffrey James Roix](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey James Roix
Chief Executive Officer at
Stingray Bio Ltd.
Profile
Jeffrey James Roix currently works at Stingray Bio Ltd., as Chief Executive Officer, Opal Therapeutics Ltd., as Director from 2021, and o2h Ltd, as Venture Partner from 2020.
Mr. Roix also formerly worked at NeoPhore Ltd., as Chief Executive Officer & Director and PhoreMost Ltd., as Chief Operating Officer from 2015 to 2018.
Mr. Roix received his undergraduate degree from Harvard Extension School.
Jeffrey James Roix active positions
| Companies | Position | Start |
|---|---|---|
Stingray Bio Ltd.
 Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Chief Executive Officer | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/07/2020 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Director/Board Member | 01/03/2021 |
Former positions of Jeffrey James Roix
| Companies | Position | End |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Chief Operating Officer | 01/04/2018 |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Chief Executive Officer | - |
Training of Jeffrey James Roix
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
- Stock Market
- Insiders
- Jeffrey James Roix
